Tata Memorial Centre signs MoU with Wipro GE Healthcare to establish ‘Cancer Research & Innovation Centre’

• MoU to collaborate on clinical research and academic engagement activities – set up a “Joint Working Group” 
• Joint Working Group to focus on key project areas and collaboration roadmap for the next 5 years

Bengaluru, India, June 4, 2025: Tata Memorial Centre (TMC), a grant-in-aid institution under the jurisdiction of Department of Atomic Energy, Government of India, today, signed a Memorandum of Understanding (MoU) with Wipro GE Healthcare Pvt. Ltd., to establish a state-of-the-art Cancer Research & Innovation Centre with Wipro GE Healthcare as the technology partner and TMC as the clinical oncology partner. The collaboration aims to strengthen clinical research and academic engagement activities with the establishment of a ‘Joint Working Group’, to determine key project areas and collaboration roadmap for the next five years.

In India, around 100 out of every 1 lakh people are diagnosed with cancer[1] and a report from the Cancer Registry Program states the incidence of cancer cases is estimated to increase by 12.8% in 2025 as compared to 2020[2]. The alarming statistics underscore the need for precision-driven, AI-enabled solutions to advance cancer care.

Dr. C. S. Pramesh, Director of Tata Memorial Hospital says, “The government is adopting a strategic, policy-driven approach to fight cancer with the establishment of day care centres, expansion of cancer care ecosystem, promoting cancer screenings and awareness programmes. However, early detection, equitable access and preventive care remain a challenge. GE HealthCare is a world leader in MedTech and as partners, we aim to enhance clinical research and promote academic engagement to transform personalized cancer care for improved outcomes cancer care.”

Chaitanya Sarawate, Managing Director, Wipro GE Healthcare South Asia, says, “In India, the estimated number of incidences of cancer cases was more than 14 lakhs in 2023.[3] Our innovations enable precision-led cancer care through an ecosystem of devices and digital solutions powered by AI. We are proud to partner with industry leaders like Tata Memorial Centre, who are among the pioneers in the fight against cancer with their expertise in research, service and education. With this partnership, we strengthen our commitment to connect every step of cancer care right from discovery, diagnosis to treatment, integrating advanced imaging technologies and AI-led solutions in the care continuum.”

The partnership aims to accelerate the development and validation of emerging technologies and digital platforms in Oncology – on AI-based applications for medical imaging, clinical workflows, hardware and software for advanced-visualization to post-process and analyse medical images. The scope also includes vetted data annotations for application-development, enterprise applications for health informatics and management to drive optimization and transform personalized cancer care for improved outcomes.

About Tata Memorial Centre

The Tata Memorial Centre (TMC) is a comprehensive cancer care center, located in Mumbai and is under the administrative control of the Department of Atomic Energy, Government of India. It is internationally recognized as a leader in health care, with a reputation for excellence in patient care, research, and medical education. TMC is ranked amongst the top cancer care centers globally catering to 55-60 thousand new cancer patients every year. TMC not only caters to patients from within the country but also from the neighboring countries.

About Wipro GE Healthcare Pvt. Ltd.

Wipro GE Healthcare Private Limited is a Joint Venture (JV) between GE Precision Healthcare LLC, USA, and Wipro Enterprises Limited, India. Established in 1990, it is one of the most successful and longest-running JVs in the region with operations spread across India, Bangladesh, Sri Lanka, Nepal, Maldives and Bhutan. The company is one of the most premium Medical Technology players in the South Asia region. Wipro GE Healthcare is focused on addressing some of the toughest healthcare challenges - helping lower maternal and infant deaths, enabling early detection of cancer, providing precision-care pathways for heart diseases, and driving better outcomes for trauma patients, among others.

About GE HealthCare Technologies Inc.

GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enabled solutions, services and data analytics. We aim to make hospitals and health systems more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected and compassionate care, while simplifying the patient’s journey across care pathways. Together, our Imaging, Advanced Visualization Solutions, Patient Care Solutions and Pharmaceutical Diagnostics businesses help improve patient care from screening and diagnosis to therapy and monitoring. We are a $19.7 billion business with approximately 53,000 colleagues working to create a world where healthcare has no limits.

GE HealthCare is proud to be among 2025 Fortune World’s Most Admired Companies™.

Follow us on LinkedIn, X, Facebook, Instagram, and Insights for the latest news, or visit our website https://www.gehealthcare.com for more information.

[1] https://pib.gov.in/PressReleasePage.aspx?PRID=2102729

[2] https://ncdirindia.org/display/wcd.aspx#:~:text=Looking%20ahead%2C%20an%20estimated%2012.8,the%20north%20and%20northeast%20regions.

[3] https://pib.gov.in/PressReleasePage.aspx?PRID=2102729